Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 9/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.55 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 6/20 | 0.53 |
| ▸ | TNKS | O95271 | 2/20 | 0.51 |
| ▸ | PARP3 | Q9Y6F1 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.50 |
| ▸ | FER | P16591 | 1/20 | 0.50 |
| ▸ | LTK | P29376 | 1/20 | 0.50 |
| ▸ | CDK8 | P49336 | 1/20 | 0.50 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.50 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8279432 | 0.80 | CREBBP (0.50) | KMT2AGAAMEN1 | |
| SCHEMBL30592979 | 0.78 | BRPF1 (0.67) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL7227738 | 0.78 | BRPF1 (0.67) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL5063195 | 0.78 | BRPF1 (0.67) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL20510203 | 0.76 | TNKS2 (0.55) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL1075473 | 0.76 | TNKS2 (0.55) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL19465426 | 0.76 | TNKS2 (0.55) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL30124448 | 0.74 | SMN1; SMN2 (0.48) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 | |
| SCHEMBL13847518 | 0.73 | CREBBP (0.55) | TNKS2ALDH1A1KDM4EPBRM1TNKS | |
| SCHEMBL8143860 | 0.72 | TNKS2 (0.56) | TNKS2ALDH1A1KDM4EHSD17B10PBRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708454-B2 | Acrolein scavenging in PTF and other 1,3-propanediol derived polymers | THE COCA-COLA COMPANY (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708454-B2 | Acrolein scavenging in PTF and other 1,3-propanediol derived polymers | THE COCA-COLA COMPANY (US) | 2023-07-25 | — | — | US | disclosed |
| US-11220589-B2 | Method of decreasing aldehyde content in a polymeric material | COLORMATRIX HOLDINGS, INC. (US) | 2022-01-11 | — | — | US | disclosed |
| US-11015036-B2 | Acetaldehyde scavenger treatment | FORD MOTOR COMPANY (US) | 2021-05-25 | — | — | US | disclosed |
| US-20200157311-A1 | METHOD OF DECREASING ALDEHYDE CONTENT IN A POLYMERIC MATERIAL | COLORMATRIX HOLDINGS, INC. | 2020-05-21 | — | — | US | disclosed |
| US-20200140646-A1 | ACETALDEHYDE SCAVENGER TREATMENT | FORD MOTOR COMPANY (US) | 2020-05-07 | — | — | US | disclosed |
| US-10557010-B2 | Acetaldehyde scavenger treatment | FORD MOTOR COMPANY (US) | 2020-02-11 | — | — | US | disclosed |
| US-10557017-B2 | Method of decreasing aldehyde content in a polymeric material | COLORMATRIX HOLDINGS, INC. (US) | 2020-02-11 | — | — | US | disclosed |
| US-20190330420-A1 | ACROLEIN SCAVENGING IN PTF AND OTHER 1,3-PROPANEDIOL DERIVED POLYMERS | THE COCA-COLA COMPANY (US) | 2019-10-31 | — | — | US | disclosed |
| US-20170349716-A1 | ACETALDEHYDE SCAVENGER TREATMENT | FORD MOTOR COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20170349722-A1 | ACETALDEHYDE SCAVENGER TREATMENT | FORD MOTOR COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20170349722-A1 | ACETALDEHYDE SCAVENGER TREATMENT | FORD MOTOR COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20170349716-A1 | ACETALDEHYDE SCAVENGER TREATMENT | FORD MOTOR COMPANY | 2017-12-07 | — | — | US | disclosed |
| US-20120088782-A1 | LPA RECEPTOR ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| US-20100249157-A2 | LPA RECEPTOR ANTAGONIST | ONO PHARMACEUTICAL CO., LTD. (JP) | 2010-09-30 | — | — | US | disclosed |
| US-4208343-A | STARTING MATERIALS FOR CYANO-IMIDE POLYMERS | WESTINGHOUSE ELECTRIC CORP. (US) | 1980-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249157-A2 | LPA RECEPTOR ANTAGONIST | LPAR1, LPAR2, LPAR4 | TNKS2 3895/4885ALDH1A1 2593/4885KDM4E 4132/4885 |
| US-20120088782-A1 | LPA RECEPTOR ANTAGONIST | LPAR1, LPAR2, LPAR4 | TNKS2 3895/4885ALDH1A1 2593/4885KDM4E 4132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.